Faisal Almesfer

Neuroscience company Exsurgo announces Jiva Muthu as COO

New Zealand neuroscience company Exsurgo has appointed experienced senior engineering executive, Jiva Muthu as Chief Operating Officer.  Muthu joins Exsurgo from Rakon – one of the world’s largest manufacturers of frequency control products and timing solutions – and has 18 years’ experience in the medical devices industry with Fisher & Paykel Healthcare, Rex Bionics and …

Neuroscience company Exsurgo announces Jiva Muthu as COO Read More »

Making [brain] waves in the UK by Richard Little, CEO, Exsurgo

At Exsurgo, our vision is to unlock the power of neuroscience to ease suffering and enhance human potential. We’re on a mission to transform the way the world treats neurological problems with effective, accessible and non-pharmaceutical solutions that harness the latest in science, technology, engineering and big data.  It’s a lofty goal, but a recent …

Making [brain] waves in the UK by Richard Little, CEO, Exsurgo Read More »

New Zealand neuroscience company Exsurgo announces success of breakthrough chronic pain management trial, UK study paves the way for larger clinical trial due to start soon in New Zealand

A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by neuroscience company, Exsurgo. Chronic pain (defined as pain that persists for longer than three months) affects up to 1 in 5 people around the world and is a massive burden on healthcare systems and economies. Chronic …

New Zealand neuroscience company Exsurgo announces success of breakthrough chronic pain management trial, UK study paves the way for larger clinical trial due to start soon in New Zealand Read More »

Newshub covers Exsurgo’s chronic pain treatment innovation, shares results of Axon’s UK trial

Newshub, one of New Zealand’s biggest news services, has reported on the potential of Exsurgo’s Axon technology to help treat chronic pain and shared the results of a proof-of-concept trial in the UK. As Laura Tupou’s story said: The answer to chronic pain management could be to retrain your brain. A Kiwi company has designed …

Newshub covers Exsurgo’s chronic pain treatment innovation, shares results of Axon’s UK trial Read More »

More and more US adults have chronic pain, new study shows

In a new study, researchers have found that the prevalence of chronic pain is increasing for all demographics of U.S. adults. The research, which appears in the journal Demography, highlights that the prevalence of chronic pain has increased the most for people from lower socioeconomic backgrounds. “We looked at the data from every available perspective, including …

More and more US adults have chronic pain, new study shows Read More »

UK medicines watchdog recommends physical and psychological therapies when treating pain with no known cause

The Guardian has reported on a significant change to guidelines for pain treatment from the UK’s National Institute for Health and Care Excellence, which say that doctors “should advise sufferers to use physical and psychological therapies rather than analgesics to manage their pain”. There is “little or no evidence” that treating the condition with painkillers makes any difference to the person’s …

UK medicines watchdog recommends physical and psychological therapies when treating pain with no known cause Read More »

Exsurgo announces John Emson as new CFO

Exsurgo has appointed experienced financial executive John Emson as its first Chief Financial Officer. Emson, who has spent over 30 years in finance and M&A across the technology, manufacturing, health and education sectors, has been working closely with Exsurgo co-founder Richard Little as an advisor to the company since last year. Exsurgo is developing technologies …

Exsurgo announces John Emson as new CFO Read More »